Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-06-12 4:27 pm Unchanged |
2025-06-11 | 13D | iTeos Therapeutics, Inc. ITOS |
TANG CAPITAL MANAGEMENT, LLC | 3,826,692 9.990% |
0 (Unchanged) |
Filing History |
| 2025-06-04 4:00 pm Purchase |
2025-05-28 | 13G | iTeos Therapeutics, Inc. ITOS |
Ridgeback Capital Investments L.P. | 1,442,959 3.800% |
1,442,959 (New Position) |
Filing History |
| 2025-05-19 5:46 pm Sale |
2025-05-15 | 13D | iTeos Therapeutics, Inc. ITOS |
RA CAPITAL MANAGEMENT L.P. | 2,134,806 4.900% |
-2,028,470 (-48.72%) |
Filing History |
| 2025-05-16 7:22 pm Purchase |
2025-05-15 | 13D | iTeos Therapeutics, Inc. ITOS |
EcoR1 Capital, LLC | 10,688,978 27.900% |
4,958,978 (+86.54%) |
Filing History |
| 2025-05-15 5:30 pm Purchase |
2025-05-13 | 13D | iTeos Therapeutics, Inc. ITOS |
MPM BioVentures 2014, L.P. | 1,803,996 4.700% |
1,803,996 (New Position) |
Filing History |
| 2025-05-15 4:35 pm Purchase |
2025-03-31 | 13G | iTeos Therapeutics, Inc. ITOS |
BIOTECHNOLOGY VALUE FUND L P | 3,075,000 8.100% |
750,000 (+32.26%) |
Filing History |
| 2025-05-15 4:15 pm Purchase |
2025-05-13 | 13G | iTeos Therapeutics, Inc. ITOS |
TANG CAPITAL MANAGEMENT, LLC | 3,826,692 9.990% |
3,604,976 (+1625.94%) |
Filing History |
| 2025-05-14 6:34 pm Purchase |
2025-05-12 | 13D | iTeos Therapeutics, Inc. ITOS |
RA CAPITAL MANAGEMENT L.P. | 4,163,276 9.900% |
504,230 (+13.78%) |
Filing History |
| 2025-05-13 7:10 pm Purchase |
2025-05-13 | 13G | iTeos Therapeutics, Inc. ITOS |
EcoR1 Capital, LLC | 5,730,000 14.900% |
3,073,360 (+115.69%) |
Filing History |
| 2025-05-08 7:43 pm Purchase |
2025-05-01 | 13G | iTeos Therapeutics, Inc. ITOS |
EcoR1 Capital, LLC | 2,656,640 6.900% |
1,048,024 (+65.15%) |
Filing History |
| 2025-04-23 8:57 pm Sale |
2025-03-31 | 13G | iTeos Therapeutics, Inc. ITOS |
BlackRock Inc. BLK |
2,179,420 5.700% |
-1,703,129 (-43.87%) |
Filing History |
| 2025-04-15 5:04 pm Purchase |
2025-03-31 | 13G | iTeos Therapeutics, Inc. ITOS |
BlackRock Portfolio Management LLC | 2,329,827 6.100% |
2,329,827 (New Position) |
Filing History |
| 2025-02-14 4:00 pm Sale |
2024-12-31 | 13G | iTeos Therapeutics, Inc. ITOS |
TANG CAPITAL MANAGEMENT, LLC | 221,716 0.600% |
-2,186,084 (-90.79%) |
Filing History |
| 2024-11-21 8:27 pm Purchase |
2024-11-14 | 13G | iTeos Therapeutics, Inc. ITOS |
BIOTECHNOLOGY VALUE FUND L P | 2,325,000 6.400% |
1,065,524 (+84.60%) |
Filing History |
| 2024-11-19 09:57 am Unchanged |
2024-11-14 | 13D | iTeos Therapeutics, Inc. ITOS |
Boxer Asset Management Inc. | 1,020,052 2.800% |
0 (Unchanged) |
Filing History |
| 2024-11-18 9:57 pm Purchase |
2024-11-14 | 13D | iTeos Therapeutics, Inc. ITOS |
Boxer Asset Management Inc. | 1,020,052 2.800% |
1,020,052 (New Position) |
Filing History |
| 2024-11-14 6:04 pm Sale |
2024-09-30 | 13G | iTeos Therapeutics, Inc. ITOS |
EcoR1 Capital, LLC | 1,608,616 4.400% |
-336,056 (-17.28%) |
Filing History |
| 2024-11-08 2:17 pm Unchanged |
2024-09-30 | 13G | iTeos Therapeutics, Inc. ITOS |
BlackRock Inc. BLK |
3,882,549 10.600% |
0 (Unchanged) |
Filing History |
| 2024-10-21 4:11 pm Sale |
2024-09-30 | 13G | iTeos Therapeutics, Inc. ITOS |
BlackRock Inc. BLK |
3,882,549 10.600% |
-379,196 (-8.90%) |
Filing History |
| 2024-10-15 9:49 pm Purchase |
2024-10-10 | 13D | iTeos Therapeutics, Inc. ITOS |
Boxer Capital LLC | 3,020,052 8.100% |
73,137 (+2.48%) |
Filing History |